Target intelligence / Profile preview

Plasmodium gametocyte

Molecular classification
Other (cellular stage)
01

Overview

Plasmodium gametocyte is the sexual precursor cell of malaria parasites, differentiated from asexual blood-stage forms. Gametocytes are highly specialized: males (microgametocytes) undergo endomitosis to produce flagellated microgametes upon transmission to the mosquito, while females (macrogametocytes) are prepared for fertilization and further development in the vector[5]. The stage is morphologically distinct, especially for *P. falciparum*, which forms the classic crescent-shaped gametocyte through complex remodeling of membrane compartments (inner membrane complex) and cytoskeletal elements (microtubules and actin filaments)[1][2][6][7]. Gametocytes do not directly cause malaria symptoms but are essential for transmission from human hosts to mosquitoes, making them a key focus for development of transmission-blocking interventions[5]. Drugs that target gametocytes can prevent dissemination of malaria in endemic regions. The biology of gametocytes involves extensive structural rearrangements, dimorphic sex differentiation, and specialized organellar architectures, all supporting their survival, release into the bloodstream, and readiness for mosquito uptake[1][2][3][6]. Note: "Plasmodium gametocyte" should not be confused with specific proteins, receptors, or enzymes; it is a cellular stage, and therapeutic targeting is aimed at killing or preventing maturation of these cells in humans to block malaria transmission[5].

Other names
gametocytemale gametocyte (microgametocyte)female gametocyte (macrogametocyte)sexual stage parasite
02

Mechanism of action

Direct gametocytocidal activity (kills gametocytes in human blood, preventing transmission); Inhibition of gametocyte maturation; Disruption of mitochondrial function

03

Biological functions

Sexual reproductionTransmission from human to mosquitoGamete productionCellular morphogenesis and cytoskeleton rearrangement
04

Disease associations

Infection (malaria transmission)
05

Safety considerations

Hemolytic risk in G6PD-deficient patients for some drugs (primaquine, tafenoquine)Limited drugs with safe and effective gametocytocidal activity, especially for late-stage gametocytes
06

Interacting drugs

Primaquine

2 more in the full profile.

07

Biomarkers

Circulating gametocyte presence (Giemsa stain, molecular detection)Gametocyte-specific proteins (e.g., Pfs25, Pfg377 for P. falciparum gametocytes)

Beyond the preview

Go deeper on Plasmodium gametocyte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium gametocyte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call